Abrysvo

Abrysvo is a vaccine designed to protect against Respiratory Syncytial Virus (RSV). It is administered intramuscularly and is manufactured by Pfizer Europe Ma Eeig. Learn more about its uses and effects.

Abrysvo is used to prevent infections caused by Respiratory Syncytial Virus (RSV). RSV is a common respiratory virus that can cause severe illness, particularly in infants and young children. The vaccine works by stimulating the immune system to produce antibodies against RSV, helping to reduce the risk of infection. What is Abrysvo used for? It is primarily used for the prevention of RSV-related illnesses, including bronchiolitis and pneumonia.

Common effects of Abrysvo may include mild to moderate reactions at the injection site, such as pain, redness, or swelling. Some individuals may also experience general symptoms like fatigue, headache, or muscle pain. These effects are typically temporary and resolve on their own within a few days. It is important to monitor for any severe or persistent symptoms and consult a healthcare provider if necessary.

Abrysvo should be handled and stored according to the manufacturer's guidelines to ensure its effectiveness. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. Always follow the advice of a healthcare professional regarding the administration and monitoring of the vaccine.

Abrysvo may interact with other medications or vaccines. It is advisable to discuss your current medications with a healthcare provider before receiving the vaccine. Certain medications, such as immunosuppressants, may affect the immune response to the vaccine. Additionally, alcohol and other substances may influence the body's ability to respond to the vaccine. Always consult a healthcare professional for personalized advice.